Research Article

The Prevalence of Single and Multiple Thyroid Nodules and Its Association with Metabolic Diseases in Chinese: A Cross-Sectional Study

Table 4

Association between metabolic diseases and multiple thyroid nodules analyzed by univariable logistic regression (N = 2961).

TotalMaleFemale
STN (N, %)MTN (N, %)OR (95% CI) valueSTN (N, %)MTN (N, %)OR (95% CI) valueSTN (N, %)MTN (N, %)OR (95% CI) value

BMI (kg/m2)
 18.5∼23.9654 (58.9)457 (41.1)1.0 (ref)1.0289 (66.7)144 (33.3)1.0 (ref)1.0365 (53.8)313 (46.2)1.0 (ref)1.0
 24∼27.9735 (56.1)575 (43.9)1.12 (0.95–1.32)0.17502 (61.9)309 (38.1)1.24 (0.97–1.58)0.09233 (46.7)266 (53.3)1.33 (1.06–1.68)0.02
 ≥28296 (54.8)244 (45.2)1.18 (0.96–1.45)0.12204 (58.5)145 (41.5)1.43 (1.07–1.91)0.0292 (48.2)99 (51.8)1.26 (0.91–1.73)0.17
Hypertension
 No1253 (58.3)898 (41.7)1.0 (ref)1.0710 (64.5)390 (35.5)1.0 (ref)1.0543 (51.7)508 (48.3)1.0 (ref)1.0
 Yes432 (53.3)378 (46.7)1.22 (1.04–1.44)0.02285 (57.8)208 (42.2)1.33 (1.07–1.65)0.01147 (46.4)170 (53.6)1.24 (0.96–1.59)0.10
Central obesity (cm)
 Male <90; female <85979 (58.3)700 (41.7)1.0 (ref)1.0493 (64.4)273 (35.6)1.0 (ref)1.0486 (53.2)427 (46.8)1.0 (ref)1.0
 Male ≥90; female ≥85706 (55.1)576 (44.9)1.14 (0.99–1.32)0.08502 (60.7)325 (39.3)1.17 (0.95–1.43)0.13204 (44.8)251 (55.2)1.40 (1.12–1.76)<0.01
High TG
 <1.73997 (56.6)764 (43.4)1.0 (ref)1.0472 (62.4)285 (37.6)1.0 (ref)1.0525 (52.3)479 (47.7)1.0 (ref)1.0
 ≥1.73688 (57.3)512 (42.7)0.97 (0.84–1.13)0.70523 (62.6)313 (37.4)0.99 (0.81–1.21)0.93165 (45.3)199 (54.7)1.32 (1.04–1.68)0.02
High TC (mmol/L)
 <5.71262 (57.8)923 (42.2)1.0 (ref)1.0730 (62.0)448 (38.0)1.0 (ref)1.0532 (52.8)475 (47.2)1.0 (ref)1.0
 ≥5.7423 (54.5)353 (45.5)1.14 (0.97–1.35)0.12265 (63.9)150 (36.1)0.92 (0.73–1.16)0.50158 (43.8)203 (56.2)1.44 (1.13–1.83)<0.01
Low HDL-C
 ≥0.91593 (56.6)1222 (43.4)1.0 (ref)1.0921 (62.6)550 (37.4)1.0 (ref)1.0672 (50.0)672 (50.0)1.0 (ref)1.0
 <0.992 (63.0)54 (37.0)0.77 (0.54–1.08)0.1374 (60.7)48 (39.3)1.09 (0.74–1.59)0.6718 (75.0)6 (25.0)0.33 (0.13–0.85)0.02
High LDL-C
 <3.11477 (58.1)1066 (41.9)1.0 (ref)1.0854 (62.9)504 (37.1)1.0 (ref)1.0623 (52.6)562 (47.4)1.0 (ref)1.0
 ≥3.1208 (49.8)210 (50.2)1.40 (1.14–1.72)<0.01141 (60.0)94 (40.0)1.13 (0.85–1.50)0.4067 (36.6)116 (63.4)1.92 (1.39–2.65)<0.01
DM (mmol/L)
 Normal929 (59.3)638 (40.7)1.0 (ref)1.0505 (64.2)282 (35.8)1.0 (ref)1.0424 (54.4)356 (45.6)1.0 (ref)1.0
 IGR464 (54.5)388 (45.5)1.22 (1.03–1.44)0.02290 (62.1)177 (37.9)1.09 (0.86–1.39)0.46174 (45.2)211 (54.8)1.44 (1.13–1.85)<0.01
 DM292 (53.9)250 (46.1)1.25 (1.02–1.52)0.03200 (59.0)139 (41.0)1.25 (0.96–1.62)0.1092 (45.3)111 (54.7)1.44 (1.05–1.96)0.02
HUA (μmol/L)
 Male ≤420; female ≤3501220 (57.2)913 (42.8)1.0 (ref)1.0631 (62.4)381 (37.6)1.0 (ref)1.0589 (52.5)532 (47.5)1.0 (ref)1.0
 Male >420; female >350465 (56.2)363 (43.8)1.04 (0.89–1.23)0.61364 (62.7)217 (37.3)0.99 (0.80–1.22)0.91101 (40.9)146 (59.1)1.60 (1.21–2.12)<0.01
MS
 No1116 (57.3)833 (42.7)1.0 (ref)1.0569 (63.5)327 (36.5)1.0 (ref)1.0547 (51.9)506 (48.1)1.0 (ref)1.0
 Yes569 (56.2)443 (43.8)1.04 (0.90–1.22)0.59426 (61.1)271 (38.9)1.11 (0.90–1.36)0.33143 (45.4)172 (54.6)1.30 (1.01–1.67)0.04
Fatty liver
 No1046 (56.9)792 (43.1)1.0 (ref)1.0506 (62.7)301 (37.3)1.0 (ref)1.0540 (52.4)491 (47.6)1.0 (ref)1.0
 Yes639 (56.9)484 (43.1)1.00 (0.86–1.16)1.00489 (62.2)297 (37.8)1.02 (0.83–1.25)0.84150 (44.5)187 (55.5)1.37 (1.07–1.76)0.01

Note: STN: single thyroid nodule; MTN: multiple thyroid nodules; BMI: body mass index; TG: triglyceride; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; IGR: sugar adjustment; DM: diabetes mellitus; HUA: hyperuricemia; MS: metabolic syndrome.